| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Bernd Brust
Also a director
Chief Executive Officer
|
59 | Not stated | Not stated | $10,129,708 | |
|
Raj Asarpota
Chief Financial Officer
|
59 |
Since 2025
1 year
|
Not stated | $3,506,793 | |
|
Kurt Oreshack
Executive Vice President, General Counsel and Secretary
|
46 |
Since 2020
6 years
|
Not stated | $1,470,977 | |
|
Christine Dolan
See Remarks
Title from the Form 4 dated May 15, 2026
|
58 | Not stated | Not stated | $1,454,198 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Tax Receivable Agreement providing for payment of 85% of certain realized tax benefits; no payments made during fiscal 2025
Director Nomination Agreement with GTCR
Registration Rights Agreement granting registration rights over Class A common stock
Indemnification agreements providing contractual rights to indemnification and expense advancement
Topco LLC operating agreement requiring cash distributions for owners' tax payments; no such distributions made in fiscal 2025
Company purchases of reagents and antigens from Curia Global
Curia Global purchases of CleanCap analogs and ELISA kits from the Company
Company purchases of ELISA substrates from Surmodics during the portion of fiscal 2025 it was affiliated with GTCR
Loading...
